Chargement en cours...
Fibroblast Growth Factor Signaling in Metabolic Regulation
The prevalence of obesity is a growing health problem. Obesity is strongly associated with several comorbidities, such as non-alcoholic fatty liver disease, certain cancers, insulin resistance, and type 2 diabetes, which all reduce life expectancy and life quality. Several drugs have been put forwar...
Enregistré dans:
| Publié dans: | Front Endocrinol (Lausanne) |
|---|---|
| Auteurs principaux: | , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4718082/ https://ncbi.nlm.nih.gov/pubmed/26834701 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2015.00193 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|